Compounds > ondansetron
Page last updated: 2024-11-01

ondansetron and Angina Pectoris

ondansetron has been researched along with Angina Pectoris in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballard, HS1
Bottino, G1
Bottino, J1
Palmer, JB1
Greenstreet, YL1

Other Studies

2 other studies available for ondansetron and Angina Pectoris

ArticleYear
Ondansetron and chest pain.
    Lancet (London, England), 1992, Oct-31, Volume: 340, Issue:8827

    Topics: Aged; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Chest Pain; Female; Humans; M

1992
Ondansetron and chest pain.
    Lancet (London, England), 1992, Dec-05, Volume: 340, Issue:8832

    Topics: Aged; Angina Pectoris; Antineoplastic Agents; Chest Pain; Humans; Neoplasms; Ondansetron; Product La

1992